Skip to main content
. 2022 Dec 1;12(12):e066766. doi: 10.1136/bmjopen-2022-066766

Table 3.

Association between the peak anti-spike IgG antibody levels 14–84 days post-second vaccination with each characteristic from the univariable model and multivariable model

Univariable Multivariable
Coefficient P value 95% CI Coefficient P value 95% CI
Age
 Per 10-year older −0.034 0.002 −0.06 −0.01 −0.03 <0.001 −0.05 −0.01
Sex
 Female 1 (ref)
 Male 0.02 0.6 −0.06 0.09 −0.04 0.14 −0.09 0.01
Ethnicity
 White 1 (ref)
 Asian 0.01 0.7 −0.06 0.09
 Black −0.22 0.009 −0.38 −0.05
 Mixed 0.07 0.5 −0.13 0.26
 Other −0.07 0.4 −0.23 0.09
Role
 Nurse/HCA 1 (ref)
 Doctor 0.1 0.1 −0.02 0.22
 Administrative staff 0.07 0.1 −0.01 0.15
 OT/PT/SLT 0.11 0.1 −0.03 0.26
 Laboratory staff 0.24 0.002 0.09 0.39
 Porter or domestic worker −0.23 0.03 −0.44 −0.03
 Medical or nursing student 0.07 0.7 −0.26 0.4
 Other −0.06 0.1 −0.14 0.01
BMI
 <16 −0.13 0.7 −0.8 0.53
 16–24.9 1 (ref)
 25–29.9 −0.06 0.1 −0.12 0.01
 30–34.9 0.01 0.9 −0.08 0.09
 35–39.9 0.01 0.9 −0.12 0.14
 40+ 0.05 0.5 −0.09 0.19
Comorbidity
 Yes vs no
 Smoking −0.17 0.003 −0.29 −0.06 −0.06 0.12 −0.14 0.02
 Pregnant 0.13 0.3 −0.11 0.37
 Asthma 0.005 0.9 −0.15 0.04
 Hypertension −0.06 0.2 −0.15 0.03 −0.06 0.09 −0.12 0.01
 Thyroid disorder (excluding malignancy) 0.01 0.9 −0.09 0.11 0.05 0.13 −0.02 0.12
 Diabetes −0.14 0.03 −0.26 −0.01 −0.14 <0.001 −0.22 −0.05
 Immunosuppression −0.38 <0.001 −0.51 −0.25 −0.22 <0.001 −0.31 −0.13
 Psoriasis −0.13 0.1 −0.3 0.04
 Heart disease 0.05 0.6 −0.14 0.25
 Non-haematological malignancy 0.14 0.1 −0.04 0.32 0.13 0.04 0.01 0.25
 Rheumatological disorder −0.28 0.01 −0.5 −0.06
 Respiratory disease (excluding asthma) −0.22 0.02 −0.41 −0.03 −0.17 0.01 −0.3 −0.04
 Haematological disease (excluding malignancy) 0.06 0.6 −0.14 0.25
 Liver disease −0.03 0.9 −0.38 0.32
 Neurological disorder −0.001 0.9 −0.33 0.33
 CKD stage 3, 4 or 5 −0.84 <0.001 −1.3 −0.37
 Lupus −0.68 0.002 −1.1 −0.24
 Splenic disorder (excluding traumatic splenectomy) −0.42 0.2 –1 0.15
 Haematological malignancy 0.13 0.7 −0.53 0.79
 Organ transplant −3.06 <0.001 −3.55 −2.57 −2.66 <0.001 −3.01 −2.31
Vaccination
 BNT162b2/BNT162b2
 ChAdOx1/ChAdOx1 −0.9 <0.001 −0.95 −0.85 −0.91 <0.001 −0.96 −0.87
Evidence of COVID-19 infection at baseline (yes vs no) 0.25 <0.001 0.18 0.33 0.29 <0.001 0.24 0.34
COVID-age score
 Per 10 score higher −0.05 <0.001 −0.06 −0.03

Bold indicates a significant p value of <0.05. The outcome was modelled in log10 scale. Variables in the multivariable model were selected using backward selection by Akaike information criteria.

BMI, body mass index; CKD, chronic kidney disease; HCA, healthcare assistant; OT/PT/SLT, occupational therapist, physiotherapist, and speech and language therapist.